132 related articles for article (PubMed ID: 3201861)
1. Nuclear DNA content and prognosis in Hürthle cell tumours of the thyroid gland.
Wallin G; Bäckdahl M; Lundell G; Auer G; Löwhagen T
Acta Chir Scand; 1988 Sep; 154(9):501-4. PubMed ID: 3201861
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of nuclear DNA content in follicular thyroid tumours.
Bäckdahl M; Auer G; Forsslund G; Granberg PO; Hamberger B; Lundell G; Löwhagen T; Zetterberg A
Acta Chir Scand; 1986 Jan; 152():1-7. PubMed ID: 3953203
[TBL] [Abstract][Full Text] [Related]
3. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
4. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
5. [DNA cytophotometry of oxyphilic thyroid tumors].
Pilch H; Back W; Winter J
Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
[TBL] [Abstract][Full Text] [Related]
6. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
Lukács GL; Balázs G; Zs-Nagy I; Mikó T
Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
[TBL] [Abstract][Full Text] [Related]
7. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy?
McHenry CR; Thomas SR; Slusarczyk SJ; Khiyami A
Surgery; 1999 Oct; 126(4):798-802; discussion 802-4. PubMed ID: 10520931
[TBL] [Abstract][Full Text] [Related]
8. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
[TBL] [Abstract][Full Text] [Related]
9. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
[TBL] [Abstract][Full Text] [Related]
10. Hürthle cell lesions in thyroid neoplasms.
Khan MS; al-Manee MS; Huzaimeh IA; Ahmad MS
Int Surg; 1989; 74(4):261-6. PubMed ID: 2625402
[TBL] [Abstract][Full Text] [Related]
11. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
[TBL] [Abstract][Full Text] [Related]
12. Hürthle cell tumors of the thyroid gland.
Heppe H; Armin A; Calandra DB; Lawrence AM; Paloyan E
Surgery; 1985 Dec; 98(6):1162-5. PubMed ID: 4071391
[TBL] [Abstract][Full Text] [Related]
13. [Clinical experience in Hurthle cell tumors].
Francomano F; Napolitano L; Scipione P; Savini F; Bajocchi G; Angelucci D
G Chir; 1998; 19(11-12):449-52. PubMed ID: 9882947
[TBL] [Abstract][Full Text] [Related]
14. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
15. Hürthle cell tumors: a twenty-five-year experience.
Arganini M; Behar R; Wu TC; Straus F; McCormick M; DeGroot LJ; Kaplan EL
Surgery; 1986 Dec; 100(6):1108-15. PubMed ID: 3787466
[TBL] [Abstract][Full Text] [Related]
16. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
17. Nuclear DNA measurements in follicular thyroid adenomas.
Bäckdahl M; Wallin G; Askensten U; Auer G; Grimelius L; Löwhagen T
Eur J Surg Oncol; 1989 Apr; 15(2):125-9. PubMed ID: 2703057
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of accordance between cytological and histopathological findings in selected thyroid tumors].
Gołkowski F; Jabrocka A; Huszno B; Trofimiuk M; Buziak-Bereza M; Kulig J; Cichoń S
Przegl Lek; 2004; 61(1):10-2. PubMed ID: 15230098
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histological differences in anaplastic thyroid carcinoma.
Rodriguez JM; Piñero A; Ortiz S; Moreno A; Sola J; Soria T; Robles R; Parrilla P
Eur J Surg; 2000 Jan; 166(1):34-8. PubMed ID: 10688214
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of nuclear DNA content in highly malignant thyroid tumors].
Lukács G; Balázs G; Zs-Nagy I; Juhász F
Wien Klin Wochenschr; 1990 Apr; 102(9):253-6. PubMed ID: 2375112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
